CD8A and cancer: While functions of CD8+ T cells were impaired in KRAS/TP53 mutant cancers, their cell-state branching trajectory seems to be unaffected by tumor mutation status, suggesting a different phenotypic plasticity compared to CD4+ T cells (Figures 4F-J).